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Abstract
Anorexia nervosa (AN) is a serious eating disorder characterized by self-starvation and extreme 
weight loss. Pseudoatrophic brain changes are often readily visible in individual brain scans, and 
AN may be a valuable model disorder to study structural neuroplasticity. Structural magnetic 
resonance imaging studies have found reduced gray matter volume and cortical thinning in acutely 
underweight patients to normalize following successful treatment. However, some well-controlled 
studies have found regionally greater gray matter and persistence of structural alterations 
following long-term recovery. Findings from diffusion tensor imaging studies of white matter 
integrity and connectivity are also inconsistent. Furthermore, despite the severity of AN, the 
number of existing structural neuroimaging studies is still relatively low, and our knowledge of the 
underlying cellular and molecular mechanisms for macrostructural brain changes is rudimentary. 
We critically review the current state of structural neuroimaging in AN and discuss the potential 
neurobiological basis of structural brain alterations in the disorder, highlighting impediments to 
progress, recent developments, and promising future directions. In particular, we argue for the 
utility of more standardized data collection, adopting a connectomics approach to understanding 
brain network architecture, employing advanced magnetic resonance imaging methods that 
quantify biomarkers of brain tissue microstructure, integrating data from multiple imaging 
modalities, strategic longitudinal observation during weight restoration, and large-scale data 
pooling. Our overarching objective is to motivate carefully controlled research of brain structure in 
eating disorders, which will ultimately help predict therapeutic response and improve treatment.
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Anorexia nervosa (AN) is an eating disorder that typically develops during adolescence and 
affects more women than men (8:1 ratio) (1). It is the third most common chronic illness in 
adolescents with the highest mortality ratio of all psychiatric disorders (2). The diagnostic 
criteria include energy-intake restriction, significantly low body weight, fear of gaining 
weight, and a distorted body image (3). Clinically, a restricting type marked by food 
restriction can be distinguished from an impulsive binge-eating/purging type, where affected 
individuals eat large amounts of food in a short time period (bingeing) and/or attempt to 
counteract weight gain by vomiting or laxative use (purging). In fact, impulse control may 
serve as a trait-based model to characterize individuals with eating disorders along a 
continuum (4). The pathophysiology remains unknown, with many interacting 
developmental, genetic, environmental, and neurobiological factors (1,5,6). Understanding 
the underlying neurobiology will be key for developing more effective treatments (7–9).
Researchers have long searched for clues in brain structure (10). Advances in neuroimaging, 
including the analysis of T1-weighted (11–13) and diffusion-weighted magnetic resonance 
images (14,15) have yielded important insights (16,17). One well-established finding is that 
gray matter (GM) reduction associated with acute malnutrition is largely reversible with 
weight restoration, at least in nonchronic cases in younger patients (Figure 1) (18–20). Other 
studies have found regionally specific GM alterations (21–23) and compromised white 
matter (WM) integrity or connectivity independent from acute malnourishment (24,25), but 
findings are inconsistent (26–30). Relationships with clinical variables are similarly diverse 
(31,32). These discrepancies may be due to differences in methods and cohorts. Compared 
with other psychiatric disorders, few large-scale studies exist, and our understanding of the 
microstructural basis for macrostructural brain changes in AN is still rudimentary.
The main goals of this review are to 1) critically appraise the current state of structural 
neuroimaging in AN, 2) discuss cellular and molecular processes that may underlie 
morphological alterations in AN, and 3) outline a blueprint for future research elucidating 
the structural architecture of the brain in the disorder. While AN can be seen as a model 
disorder for understanding neuroadaptation to changing metabolic situations, the primary 
objective of this article is to motivate well-controlled research to help predict therapeutic 
response and eventually improve treatment. A cornerstone of this endeavor is promoting 
more standardized study protocols and large-scale data pooling and encouraging future 
studies with advanced technologies that integrate endocrine, metabolic, and (epi)genetic 
biomarkers.
STRUCTURAL NEUROIMAGING TECHNIQUES IN AN RESEARCH
Brain imaging can evaluate the structure and function of the living brain, pointing to 
mechanisms related to pathophysiology. A benefit of studying brain structure is that it tends 
to be more stable and less dependent on acute emotional and motivational states compared 
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with functional neuroimaging. While early computed tomography studies in AN (33) were 
limited in their ability to detect localized alterations, recent structural magnetic resonance 
imaging (MRI) studies employed more sophisticated scanning and analysis procedures.
Volumetry based on T1-weighted MRI is one of the most frequently used techniques to 
study brain macrostructure. The introduction of voxel-based morphometry revolutionized 
structural neuroimaging, as it enabled automated quantification of GM and WM density 
from MRI intensity gradients (11). Most studies of AN focused on cortical and/or 
subcortical volume (26–29). However, cortical GM volume is a composite measure 
comprising two independent components: cortical thickness and surface area (34). Recent 
AN studies evaluated cortical thickness (20,35), folding, or gyrification (36,37).
Brain WM volume is often altered in psychiatric disease, including AN (28,29), but little is 
known about specific alterations in various disorders (38). Going beyond WM volume, 
several recent AN studies (39–41), including longitudinal observations (42–44), employed 
diffusion tensor imaging (DTI) (Supplemental Table S1), which provides information on 
WM integrity by quantifying water diffusivity along axons (45). The most common metric is 
fractional anisotropy (FA), a scalar value that describes the degree of anisotropic and/or 
directional diffusion associated with axon diameter, fiber packing density, membrane 
permeability, and myelination. FA is typically interpreted as a marker for WM integrity, but 
it is affected by several processes and cannot provide a definitive mechanistic explanation 
(46). To better characterize dynamic (pathological) microstructural abnormalities, DTI 
studies often include additional measures, including mean diffusivity—an overall measure of 
water diffusion—and measures of diffusion perpendicular or parallel to WM tracts (radial 
and axial diffusivity). Recent studies used DTI tractography to investigate WM fiber 
connectivity (25,43,47) measured by so-called streamlines that identify connection density 
and quality.
CURRENT STATE OF STRUCTURAL NEUROIMAGING RESEARCH IN AN
The increasing number of structural neuroimaging studies in AN (Figure 2) have been 
qualitatively reviewed and quantitatively meta-analyzed (Supplement) (26–30). The most 
comprehensive meta-analysis (28,29) concluded that globally reduced GM and WM volume 
in acutely underweight patients with AN normalizes during weight restoration, suggesting 
that alterations may merely reflect malnourishment. However, some well-controlled studies 
found larger frontal and subcortical volumes (22,39,48,49), and some regions, including 
cingulate gyrus (21,48,50) and cerebellum (31,32,51–53), appear to be altered more 
frequently than others. Furthermore, adolescents and adults may differ in the persistence and 
prognostic implications of structural alterations. Reports relating GM differences to clinical 
variables or cognitive function (19,22,32,54,55) are also heterogeneous—the only reliable 
predictor is body mass index (20,31,35,56). Similarly diverse findings from the small DTI 
literature in AN (Supplemental Table S1) hint at altered anisotropy and/or diffusivity in a 
range of WM tracts, including the cingulum, corpus callosum, superior longitudinal 
fasciculus, and, most frequently, fornix (17,30). However, the fornix is particularly 
susceptible to artifacts (57,58). Moreover, some studies report both increased and decreased 
FA in varying brain regions (40,42) or no differences at all (41).
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Thus, further research, particularly in weight-recovered individuals and accounting for 
potential differences between clinical subtypes, is needed (25,43,59,60). Recent analyses of 
WM structural and effective connectivity (43,44,47,60) point to alterations in reward-
regulating frontostriatal circuitry, but a coherent pattern has yet to emerge (Figure 3). As 
discussed below, these inconsistencies are likely due to several factors, some of which are 
methodological, which should be addressed in future studies.
Sample Size
Most studies have had small sample sizes (n < 20 patients) and low statistical power, 
inflating the likelihood of false-positive and false-negative results (61,62). A few recent 
studies compiled samples including more than 40 patients with AN (19,20,31), but none 
have conducted power calculations to determine sample sizes needed to detect reliable 
effects. Some studies have minimized the threat of unreliable findings by controlling for 
potential confounds (discussed below) and using stringent statistical thresholds controlled 
for multiple comparisons. Although the diverse results to date may reflect true heterogeneity 
in AN, progress will likely come from better-powered studies. As large samples are hard to 
recruit in a disorder often characterized by lack of illness insight and compliance, 
researchers should consider pooling data (see Advancing the Neuroscience of AN Through 
Collective Analysis below).
Nutritional Status
Modern neuroimaging can detect day-to-day changes in brain structure (63), and diet can 
influence brain morphometry (64). Studies should therefore carefully control and assess 
dietary intake, for example, by scanning at the same time of day after a standardized 
nutritional regimen. While some studies are vague regarding the nutritional status (37,40), 
others report scanning within the first days of patient care in a highly controlled environment 
(19,20,41–43), and still others report scanning after initial realimentation (1–2 weeks) 
(22,35,39). The former strategy captures AN in the natural disease state, but the latter 
reduces the effects of extreme malnutrition. Both strategies offer advantages, but future 
research should clarify the impact of initial realimentation by tracking body mass index 
change before scanning and longitudinal observation. Reversal of pseudoatrophy after 
weight restoration may be more rapid than previously thought (20,65).
Hydration
Hydration affects brain structure (66), and fluid intake is often abnormal in patients with AN 
(67). Three studies asked whether brain abnormalities in acute AN may reflect dehydration 
(22,24) by measuring urine specific gravity but found no evidence of dehydration or 
relationships with brain morphology (19,20,42). However, since self-induced dehydration 
and hyperhydration, together with impaired osmoregulation (68), are common in AN, and 
patients may “cheat the scale” by drinking excessively, targeted study is still needed, for 
instance, of water content (69).
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Brain Development
The brain undergoes plastic changes across the life span (70), and it is challenging to 
disentangle developmental effects from insults due to malnutrition or neuroendocrine 
dysregulation in AN (71–73). Neurodevelopmental trajectories may be interrupted in AN, 
but the effects of malnutrition are at least one order of magnitude faster than age-related 
changes (20). While many AN studies attempt to account for maturation affects by 
covarying for age, others have adopted the often favorable strategy of focusing on 
homogeneous age ranges in separate analyses (19,22,39,41).
Extraneous Variables
In addition to controlling for eating disorder–specific factors, including clinical subtype (and 
subtype history), age of illness onset, and illness duration, future studies should control for 
other potential confounds, such as comorbidity (1,5), medication (74) including oral 
contraceptives (75), menstrual cycle (76), physical activity (77), and, in adolescents, pubertal 
stage (78). For analyses, use of covariates should be kept to a minimum to avoid overfitting 
statistical models. Depending on specific research questions, subanalysis of the influence of 
variables that are present only in the clinical group is important, both within-group (e.g., 
duration of illness) and between-(sub) group (e.g., medication) analyses.
Enhancing Reproducibility and Generalizability
Researchers are encouraged to follow best practices in neuroimaging (79) and to take 
proposed guidelines (Table 1) into consideration, many of which apply generally to eating 
disorders.
POTENTIAL NEUROBIOLOGICAL MECHANISMS UNDERLYING 
STRUCTURAL BRAIN ALTERATIONS IN AN
Alterations in brain structure may result from multiple processes, but the underlying 
mechanisms remain poorly understood (80). In this section, we discuss possible explanations 
for brain morphological changes in AN, including 1) intracellular fluid moving into 
extracellular spaces because of altered oncotic (colloid osmotic) pressure or dehydration 
(81); 2) loss of glial or neuronal cells (e.g., apoptosis); 3) macronutrient and/or 
micronutrient deficiency (82,83); and 4) suppression of leptin (84), reduction of gonadal and 
thyroid hormones as well as neurotrophins, and cortisol increase (72). The last-mentioned 
possibilities could contribute to inadequate protein biosynthesis, which may lead to a) 
changes in or loss of dendritic spines, fiber reorganization, and delayed synaptogenesis 
(neuronal remodeling) and b) increased lipid catabolism and/or decreased myelination and 
shrinkage of glial cells (glial remodeling).
Dehydration and Oncotic Pressure
As noted above, targeted studies are needed to confirm preliminary evidence indicating that 
dehydration may not explain GM reduction in acute AN (19,20,42). Additional measurement 
methods, such as bioelectrical impedance analysis (with vector analysis), may also be 
helpful (85). It would also be important to differentiate between hypovolemia that is due to 
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dehydration and hypovolemia that is due to loss of electrolytes, and researchers need to take 
into account that hemoconcentration that is due to volume depletion in AN can be masked 
by anemia (86). Fluctuations in GM and/or WM characteristics might also be explained by 
changes in oncotic pressure related to fluid shifts between the circulatory system and the 
interstitial space. Indeed, free abdominal fluid and pericardial effusion are often found in 
acutely underweight patients with AN (87). Although serum protein values are normal in 
AN (88,89), albumin levels have been associated with alterations in MRI signal intensity 
(90), and exploration of relationships with morphological changes may be worthwhile.
Apoptosis of Brain Cells
Postmortem histological data from an AN case study suggest an abnormally slender neuron 
type with a long basal dendritic field and reduced spine density and/or altered spine 
morphology indicative of cellular degeneration (91). Animal models of AN show reduced 
proliferation of brain cells but not massive cell loss (92). If apoptosis were the underlying 
cause of GM loss in acute AN, normalization following weight restoration would be unlikely 
unless neurogenesis occurred. However, the rapid GM increase during therapy (roughly 4% 
globally in only 3 months) (20) is hardly compatible with the comparatively sluggish 
turnover rate documented in select neuronal subpopulations in adults (1%–2% annually) 
(93). Preliminary findings from studies using neuronal and glial damage and/or activation 
markers, such as neuron-specific enolase and glial fibrillary acid protein (GFAP) (94), speak 
against a massive acute loss of brain cells. However, the normal age-dependent increase in 
peripheral GFAP (95), which may reflect expansion of mature, differentiated astrocytes (96), 
is absent in acute AN. Thus, reductions in size or changes in morphology of glia or neurons 
and dendrites seem more likely candidates for brain changes in AN.
Dietary Intake: Macronutrients and Micronutrients
Patients with AN disproportionally avoid consuming fats (97,98). Consequently, plasma 
concentrations of several lipids (including essential fatty acids) are lower or altered in 
patients with acute (99,100) but normal in recovered patients (101). Lipids (especially 
cholesterol, glycerophospholipids, and sphingolipids) are major components of brain 
structure (102). Many fatty acids can be produced endogenously, but some polyunsaturated 
fatty acids that are crucial for fluidity of neuronal membranes and for modification of the 
number and affinity of membrane bound enzymes, receptors, and ionic channels must be 
provided by diet (103). Deficiency of polyunsaturated fatty acids has been associated with 
structural brain alterations (64), but such relationships have yet to be explored in AN.
Insufficient intake of fats and other macronutrients may also be associated with inadequate 
micronutrient intake. Few studies have investigated intake or plasma levels of vitamins and 
trace elements (including iron), but there may be a reduction of several micronutrients, 
especially vitamin B12 and zinc (104). Zinc deficiency has been suggested to play a causal 
role in AN (105), but a recent large study found reduced levels in only 3% of the adult 
patients, and other vitamin or mineral deficiencies were found in only approximately 45% of 
patients—less than expected given frequent dermatological symptoms in AN suggestive of 
micronutrient deficiency (106).
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Similarly, iron deficiency is surprisingly uncommon in AN (107). Iron is one of the many 
constituents of myelin, and iron concentration is related to WM fiber integrity (108). For 
example, higher serum transferrin levels are associated with lower fractional anisotropy in 
various WM tracts (109). Although the consequences of micronutrient deficiencies on 
neurological function have long been known (e.g., vitamin B1 and Wernicke 
encephalopathy), the study of how nutrients affect brain structure is relatively new 
(82,83,110) and has been neglected in AN research. Because evaluating micronutrient intake 
using questionnaires may be unreliable (111), measuring plasma levels may be preferable.
Endocrine System
The hypothalamic-pituitary-adrenal axis is hyperactive in AN, and the “hunger hormone” 
ghrelin is elevated, whereas the hypothalamic-pituitary-thyroid and hypothalamic-pituitary-
gonadal axes and the adipocyte-derived hormone leptin is suppressed (71,72). Cortisol 
concentrations are elevated in AN (112), and cortisol is known to impact brain structure 
(113). Suppression of the hypothalamic-pituitary-thyroid and hypothalamic-pituitary-
gonadal axis in AN has been attributed to restricted energy intake or increased energy 
expenditure and may be an adaptation to low energy availability—i.e., sexual reproduction 
would cost energy required for vital body functions. Beyond their role in sexual 
differentiation, gonadal steroids are critical for brain development, especially during 
adolescence (114). Estradiol, for example, protects neurons from excitotoxins and oxidative 
stress (115) and promotes dendritic growth, neurotransmitter synthesis, and neuronal 
depolarization (116). Despite endocrine dysregulation in AN, few studies have investigated 
relationships with brain structure. One computed tomography study (117) found associations 
between the width of cortical sulci and hypercortisolemia and hypogonadotropic 
hypogonadism, which is compatible with an MRI study reporting a link between follicle-
stimulating hormone and regional GM volumes (51). Another study found an increase in 
global GM volume following weight recovery to correlate negatively with blood cortisol 
levels (54). Given established relationships between leptin and GM volume in healthy 
individuals (118), future studies might seek to clarify the relative contribution of leptin 
deficiency to structural brain anomalies in AN.
NEUROTROPHIC FACTORS
Neurotrophin brain-derived neurotrophic factor (BDNF), nerve growth factor, and glial-
derived neurotrophic factor are proteins that modulate neuronal or glial development or 
regeneration and have been repeatedly related to brain changes. BDNF promotes the growth, 
differentiation, and survival of neurons (119) and plays a role in synaptic plasticity (120) as 
well as food intake and weight regulation (121). Reduced BDNF levels in acute AN are well 
established (122,123), as are variations in GM and WM morphometry as a function of 
BDNF polymorphisms (124). However, studies testing associations between circulating 
BDNF (and nerve growth factor and glial-derived neurotrophic factor) and brain structure in 
AN are lacking. Future studies should control for phasic effects of exercise on BDNF levels 
(125), as up to 70% of patients with AN report excessive exercise (126).
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Glial and/or Neuronal Remodeling
Even if the factors discussed above do not cause apoptosis, they may contribute to structural 
brain alterations in AN by affecting the size or shape of neurons and glia. This hypothesis is 
supported by findings of deficits in somal size and density as well as dendritic branching and 
spine density of hippocampal pyramidal cells in protein-malnourished rats (127). Similarly, 
short apical dendrites, fewer spines, and dendritic spine abnormalities have been found in 
infants with severe malnutrition (128). Such mechanisms of neuronal remodeling have been 
demonstrated to underlie MRI-detectable brain volume increases following cognitive 
training in rodents (129). Thus, neuronal-glial remodeling seems to be a plausible 
explanation of structural brain changes in AN.
The most established animal model, the activity-based anorexia model (130,131), offers 
clues to specific mechanisms in AN. As noted above, one study showed decreased cell 
proliferation suggestive of reduced gliogenesis (92). Also in line with the glial remodeling 
hypothesis, another study (132) found chronically starved rats to have reduced cerebral 
cortex and corpus callosum volumes and a lower immunoreactive surface area for GFAP-
positive astrocytes but not neurons or oligodendrocytes. Similarly, using an alternative AN 
rat model, acute dehydration-induced anorexia, another study found a reduced number of 
GFAP-positive astrocytes in the corpus callosum (133). Although most research focuses on 
neurons, astrocytes also regulate neuronal activity, protect against inflammation, support the 
blood-brain barrier, and supply energy to neurons (134). Smaller or less mature (remodeled), 
fewer, and less functional astrocytes may thus worsen the already precarious metabolic 
situation of neurons in acutely underweight patients with AN.
FUTURE DIRECTIONS OF STRUCTURAL NEUROIMAGING RESEARCH IN 
AN
Controlling for confounds is critical, but progress will likely be driven by exploring brain 
network architecture—the so-called structural connectome (135,136)—employing 
acquisition methods that quantify biomarkers of brain tissue microstructure (quantitative 
MRI [qMRI]) (137), integrating data from multiple modalities (multimodal imaging) (138) 
as well as longitudinal observation during weight restoration and large-scale data pooling. 
Conventional analytic approaches neglect the network complexity of the underlying 
neurocircuitry. Investigating interregional correlations of GM morphology (139) or systems-
level changes in connectivity by modeling the neural network architecture of GM brain 
regions (nodes) highly interconnected by WM fiber bundles (edges) (135) may be a 
promising way to bring clarity to the diverse regional abnormalities in GM and WM 
integrity reported in AN. Several recent studies have adopted a connectomics approach to 
both DTI (Figure 3) (25,43,47,60) and functional MRI data (140,141), but we are far from a 
comprehensive understanding of altered connectivity in AN.
As T1-weighted MRI data are uninformative regarding underlying tissue properties and DTI 
data in AN are inconclusive (Supplemental Table S1), more sensitive measures are needed. 
Rapidly developing qMRI methods are promising in this respect. By decoupling different 
contrast mechanisms from the overall MRI signal, qMRI directly measures surrogate 
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markers of microscopic tissue properties (137). For example, quantitative mapping of R1 
(water proton relaxation rate) indexes myelination (142) and may help in understanding 
changes in WM volume and integrity in AN. Similarly, qMRI methods might clarify the 
potential contribution of hydration and/or dietary intake as noted above by assessing, for 
instance, water (69) and iron content (108). The only known qMRI study in AN found, in 
addition to both increased and decreased fractional anisotropy in a number of WM tracts, 
reduced R1 in several tracts, suggesting that impaired WM integrity reflects myelin loss 
(40).
Combining and integrating data obtained with different modalities such as qMRI and DTI 
(40) promises to foster a greater understanding of the underlying mechanisms of structural 
brain changes in AN than can be achieved using one method alone (138). For example, two 
recent multimodal imaging studies combining diffusion tractography and functional MRI 
found evidence linking alterations in WM structural connectivity and functional and 
effective connectivity between brain regions implicated in aberrant reward processing in AN 
(Figure 3) (43,47). To date, no AN studies have capitalized on the cross-information 
provided by integrating data from multiple modalities (e.g., GM density and WM integrity) 
as enabled, for instance, with joint independent component analysis (143).
Whereas the majority of previous structural neuroimaging studies in AN have been cross-
sectional, a positive recent development has been the increase of longitudinal studies (20,42–
44), which can be particularly informative regarding the biological mechanisms underlying 
morphological alterations associated with weight rehabilitation. For example, the rapid 
increase of cortical thickness following brief weight restoration therapy (3–4 months) speaks 
against hypotheses of apoptosis and neurogenesis and for a neuronal and/or glial remodeling 
explanation (20). Studying brain structure in AN at multiple time points during recovery is 
also potentially informative regarding therapeutic response, which may help find better 
treatments.
ADVANCING THE NEUROSCIENCE OF AN THROUGH COLLECTIVE 
ANALYSIS
As noted above, sample sizes in the structural neuroimaging literature on AN are typically 
small and do not, on their own, have adequate statistical power to answer more subtle 
research questions. For example, no study to date has compiled samples including 
individuals across the entire eating disorder spectrum to account for the transdiagnostic 
nature of AN and how brain structure might be related to symptom fluctuation along a 
restrictive-impulsive continuum or based on subtype history (4,144). Data from different 
studies are also often difficult to compare owing to methodological heterogeneity, but they 
are nonetheless invaluable because they provide clinical phenotyping. In 2009, researchers 
expert in large-scale neuroimaging or genetics formed a network called Enhancing 
NeuroImaging Genetics through Meta-Analysis (ENIGMA) (http://enigma.usc.edu/) (145). 
ENIGMA has now pooled MRI and genome-wide genotyping data from greater than 30,000 
individuals to discover more than 20 genetic loci affecting brain structure. In psychiatric 
disorders, ENIGMA has completed some of the largest collaborative neuroimaging studies 
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to date including well over 3000 datasets each, with studies in progress in 18 conditions 
(146).
ENIGMA has used both a mega-analysis model, where all phenotypic data are analyzed at a 
central site, and a meta-analysis model, where analyses are run cooperatively across 
consortia sites with a pre-agreed protocol. For example, universal pre-processing, including 
quality control and analysis of T1-weighted MRI, is run locally using FreeSurfer (http://
freesurfer.net/) with pre-agreed covariates. Subsequently, site-specific regression coefficients 
are combined and meta-analyzed, weighting the results based on the sample sizes of each 
contributing cohort. Once a network is established, all members can submit proposals with 
new research questions.
In 2016, an ENIGMA AN consortium (http://enigma.usc.edu/ongoing/enigma-anorexia/) 
dedicated to understanding structural brain changes in patients over the course of weight 
restoration and recovery was founded. While harmonizing acquisition and analysis of 
neuroimaging data across different scanners is generally challenging, and it is unclear, for 
instance, how cultural factors might influence brain structure in different AN subtypes, 
increased statistical power achieved by data pooling will allow for the examination of the 
contributing or modulating factors discussed in this review as well as the specificity of 
morphological alterations compared with other (eating) disorders.
The ENIGMA screen of genetic loci that affect the brain has revealed overlap between loci 
associated with brain morphometry and schizophrenia (147). The Psychiatric Genetics 
Consortium recently identified a genome-wide significant locus in AN on chromosome 12 
(148). Additional analysis suggests positive genetic correlations with schizophrenia, 
educational achievement, and neuroticism and negative correlations with high body mass 
index and metabolic markers (148–150). Future studies could jointly screen the genome for 
loci associated with AN and brain measures, allowing, for the first time, causal inferences 
about brain differences related to genetic risk for AN.
CONCLUSIONS
Progress in understanding structural brain alterations in AN (and eating disorders generally) 
has been hindered by small sample sizes, methodological heterogeneity, and inadequate 
control for confounding variables (Table 1). In addition to outlining some steps future 
studies should take to avoid the shortcomings in the previous literature, this review focused 
on the largely overlooked question of what neurobiological mechanisms (e.g., glial 
remodeling) may underlie macromorphological changes in AN. Recent momentum in the 
field, including the application of innovative technologies and advanced analysis, is 
encouraging. The quest to identify brain regions and biological processes involved in AN 
will be further expedited by collective pooling of imaging, clinical, and genetic data. 
Harmonized global data pooling as in ENIGMA offers a new source of power to test 
associations between brain measures, treatments, and outcomes and to establish the 
reproducibility and generality of findings, which is especially important in a severe illness 
such as AN with low prevalence.
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Figure 1. 
Rapid macrostructural brain changes in anorexia nervosa during weight restoration. Selected 
sagittal (top panel), coronal (middle panel) and axial (bottom panel) T1-weighted magnetic 
resonance images of (A) an acutely underweight adolescent patient with anorexia nervosa at 
admission to an inpatient eating disorder treatment (age, 15.6 years; body mass index, 16.2) 
and (B) the same patient 14 weeks later at discharge following weight restoration therapy 
(body mass index, 19.5). The images demonstrate widespread sulcal enlargement and 
marked ventricle dilation in illness and rapid normalization following nutritional 
rehabilitation. To illustrate the dynamic alteration in brain structure in anorexia nervosa 
objectively, this patient was chosen from the longitudinal sample from Bernardoni et al. (20) 
based on her standardized body mass index change score between admission and discharge, 
which was equal to the sample mean. Note that changes apparent in single-subject raw 
magnetic resonance images may not be representative of changes detected in group analyses 
of processed images, which may include regionally increased brain mass both in the 
underweight stage and after long-term recovery (22,49).
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Figure 2. 
Structural magnetic resonance imaging (MRI) and diffusion tensor imaging (DTI) studies in 
anorexia nervosa. Graph depicts the increasing number of structural MRI and DTI studies in 
anorexia nervosa samples (n > 2 patients) published since the first known study in 1990 until 
July 2017 as identified with systematic PubMed and Scopus searches using the following 
terms: anorexia nervosa, eating disorders, MRI, magnetic resonance imaging, neuroimaging, 
DTI, diffusion tensor imaging, diffusion-weighted imaging. References for all studies 
counted in the graph are presented in the Supplement.
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Figure 3. 
State-of-the-art structural neuroimaging research in anorexia nervosa (AN). (A) Using a 
connectomics approach (135,136) to compare network modularity (139) in diffusion tensor 
imaging data (whole-brain white matter tractography) acquired from weight-restored 
patients with AN (n = 24) and healthy control (HC) subjects (n = 31), Zhang et al. (60) 
found abnormal community structure in AN in a network composed of the caudate, 
pallidum, nucleus accumbens, and rostral and caudal anterior cingulate and posterior 
cingulate (orange regions). (B) In a longitudinal multimodal analysis (138,143) of diffusion 
tensor imaging and resting-state functional magnetic resonance imaging data collected in 
acutely underweight patients with AN (n = 22) and HC subjects (n = 18), Cha et al. (43) 
found increased structural connectivity, increased white matter fractional anisotropy, and 
increased functional connectivity as well as altered effective connectivity in a reward-related 
frontoaccumbal network in AN before treatment. Structural connectivity between the 
nucleus accumbens (NAcc) and left orbitofrontal cortex (lOFC) (top) continued to be 
abnormally increased relative to HC subjects following weight restoration (bottom left), and 
fractional anisotropy remained elevated (bottom right; red region). (C) In another 
multimodal analysis of diffusion tensor imaging and functional magnetic resonance imaging 
data during taste processing collected in acutely underweight patients with AN (n = 26), 
Frank et al. (47) found altered (increased and decreased) structural connectivity in food 
reward–regulating circuitry in patients with AN relative to HC subjects (n = 26) and an 
inverted pattern of effective connectivity between the hypothalamus and ventral striatum 
driven by the anterior cingulate. (D) In a longitudinal investigation of acutely underweight 
patients with AN (n = 35), Bernardoni et al. (20) found a global increase of cortical gray 
matter thickness (84% of the cortical surface) following brief weight restoration therapy (≈3 
months following admission to a specialized nutritional rehabilitation program) and relative 
normalization compared with both long-term weight recovered patients with AN (n = 34) 
and HC subjects (n = 75). The heat map depicts regions of the lateral (top) and medial 
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(bottom) surface of the brain in both hemispheres showing significantly increased cortical 
thickness between baseline (within 96 hours after admission) and follow-up measurement 
after a minimum 10% body mass index increase. ACC, anterior cingulate cortex; mOFC, 
medial orbitofrontal cortex.
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Table 1
Factors to Consider in AN Structural Neuroimaging Research (Author Consensus)
Category Variable
Demographic Variables Sample size (sufficient statistical power)
Age range (control for age effects and/or pairwise matching or restrict age range in analysis)
In adolescents: pubertal stage (e.g., via self-report based on Tanner stage)
Clinical Variables AN subtype and subtype history (restricting vs. binge-eating/purging type)
Duration of illness
Psychiatric and severe medical comorbidities (standardized assessment)
Medication including oral contraceptives
Time and weight gain between start of realimentation and scanning
Nutritional regimen (e.g., scan before breakfast and after standard meal and/or dietary intake assessment)
Hydration (e.g., by measuring urine specific gravity or using bioelectrical impedance analysis)
Physical activity (self-report)
Menstrual cycle (self-report)
Study Design and 
Technology
Scan at standardized time of day
Analyze and control for head motion during MRI (especially for DTI)
Use up-to-date MRI sequences (resolution, signal-to-noise)
Control for different scanner platforms and changes in MRI sequences if applicable
Statistics Use up-to-date image analysis software
Systematic quality control of imaging data and outlier analysis (raw images and post-processing)
Conservative use of covariates and appropriate analysis of potential confounds that occur only in the clinical 
group
Control for multiple comparisons
AN, anorexia nervosa; DTI, diffusion tensor imaging; MRI, magnetic resonance imaging.
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